Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) have been given an average rating of “Reduce” by the six research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and five have issued a hold recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $17.25.
Several research analysts recently commented on the company. BTIG Research dropped coverage on Simulations Plus in a research note on Wednesday, October 7th. They set a “neutral” rating for the company. Weiss Ratings reiterated a “sell (d+)” rating on shares of Simulations Plus in a research note on Tuesday, October 6th.
Check Out Our Latest Report on SLP
Institutional Trading of Simulations Plus
Several hedge funds have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC acquired a new stake in shares of Simulations Plus in the 2nd quarter valued at $26,000. Farther Finance Advisors LLC grew its stake in shares of Simulations Plus by 242.6% during the third quarter. Farther Finance Advisors LLC now owns 1,384 shares of the technology company’s stock worth $26,000 after purchasing an additional 980 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Simulations Plus by 26.0% during the second quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock worth $52,000 after purchasing an additional 585 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in Simulations Plus by 59.3% in the first quarter. PNC Financial Services Group Inc. now owns 4,485 shares of the technology company’s stock valued at $53,000 after buying an additional 1,669 shares during the last quarter. Finally, Fifth Third Bancorp purchased a new position in Simulations Plus in the first quarter valued at $54,000. Institutional investors and hedge funds own 78.08% of the company’s stock.
Simulations Plus Price Performance
Shares of SLP stock opened at $18.50 on Friday. Simulations Plus has a 52 week low of $11.09 and a 52 week high of $21.01. The stock has a market capitalization of $374.16 million, a PE ratio of 46.25 and a beta of 1.31. The firm has a 50 day moving average of $18.48 and a two-hundred day moving average of $16.28.
Simulations Plus Company Profile
Simulations Plus, Inc. develops software and provides consulting services for the pharmaceutical and biotechnology industries. Its tools help researchers model how drugs behave in the body, assess drug properties, and support decisions during drug discovery and development. The company’s products include GastroPlus for physiologically based pharmacokinetic modeling and simulation, ADMET Predictor for estimating absorption, distribution, metabolism, excretion and toxicity properties, and MonolixSuite for pharmacometrics and quantitative pharmacology.
See Also
- Five stocks we like better than Simulations Plus
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
